Middle East and Africa Pharmacogenomics Market

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028

Analysis By Technology (PCR, Sequencing, Microarray, Gel Electrophoresis, Mass Spectrometry, and Others), Application (Drug Discovery, Oncology, Neurology and Psychiatry, Pain Management, Cardiovascular Diseases, and Others), and End User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others)

No. of Pages: 155
Report Code: TIPRE00028866
Category: Life Sciences
Middle East and Africa Pharmacogenomics Market
Free Sample Buy Now

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. Middle East and Africa Pharmacogenomics Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. Middle East and Africa Pharmacogenomics Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. Middle East and Africa Pharmacogenomics Market Regional Analysis

6.2 Middle East and Africa Pharmacogenomics Market Revenue 2019-2028 (US$ Million)
6.3 Middle East and Africa Pharmacogenomics Market Forecast Analysis

7. Middle East and Africa Pharmacogenomics Market Analysis – by Technology

7.1 PCR
  • 7.1.1 Overview
  • 7.1.2 PCR: Middle East and Africa Pharmacogenomics Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 Sequencing
  • 7.2.1 Overview
  • 7.2.2 Sequencing: Middle East and Africa Pharmacogenomics Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.3 Microarray
  • 7.3.1 Overview
  • 7.3.2 Microarray: Middle East and Africa Pharmacogenomics Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.4 Gel Electrophoresis
  • 7.4.1 Overview
  • 7.4.2 Gel Electrophoresis: Middle East and Africa Pharmacogenomics Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.5 Mass Spectrometry
  • 7.5.1 Overview
  • 7.5.2 Mass Spectrometry: Middle East and Africa Pharmacogenomics Market – Revenue and Forecast, 2019-2028 (US$ Million)

8. Middle East and Africa Pharmacogenomics Market Analysis – by Application

8.1 Drug Discovery
  • 8.1.1 Overview
  • 8.1.2 Drug Discovery: Middle East and Africa Pharmacogenomics Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.2 Oncology
  • 8.2.1 Overview
  • 8.2.2 Oncology: Middle East and Africa Pharmacogenomics Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.3 Neurology and Psychiatry
  • 8.3.1 Overview
  • 8.3.2 Neurology and Psychiatry: Middle East and Africa Pharmacogenomics Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.4 Pain Management
  • 8.4.1 Overview
  • 8.4.2 Pain Management: Middle East and Africa Pharmacogenomics Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.5 Cardiovascular Diseases
  • 8.5.1 Overview
  • 8.5.2 Cardiovascular Diseases: Middle East and Africa Pharmacogenomics Market – Revenue and Forecast, 2019-2028 (US$ Million)

9. Middle East and Africa Pharmacogenomics Market Analysis – by End User

9.1 Hospitals and Clinics
  • 9.1.1 Overview
  • 9.1.2 Hospitals and Clinics: Middle East and Africa Pharmacogenomics Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.2 Biopharmaceutical Companies
  • 9.2.1 Overview
  • 9.2.2 Biopharmaceutical Companies: Middle East and Africa Pharmacogenomics Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.3 CROs and CDMOs
  • 9.3.1 Overview
  • 9.3.2 CROs and CDMOs: Middle East and Africa Pharmacogenomics Market – Revenue and Forecast, 2019-2028 (US$ Million)

10. Middle East and Africa Pharmacogenomics Market – Middle East and Africa Analysis

10.1 Overview

10.2 Middle East and Africa
  • 10.2.1 Middle East and Africa Pharmacogenomics Market Breakdown, by Key Country, 2022 and 2028 (%)
  • 10.2.1.1 Middle East and Africa Pharmacogenomics Market – Revenue and Forecast Analysis – by Country
  • 10.2.1.1 South Africa: Middle East and Africa Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.1.1 South Africa: Middle East and Africa Pharmacogenomics Market Breakdown, by Technology
    • 10.2.1.1.2 South Africa: Middle East and Africa Pharmacogenomics Market Breakdown, by Application
    • 10.2.1.1.3 South Africa: Middle East and Africa Pharmacogenomics Market Breakdown, by End User
  • 10.2.1.2 Saudi Arabia: Middle East and Africa Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.2.1 Saudi Arabia: Middle East and Africa Pharmacogenomics Market Breakdown, by Technology
    • 10.2.1.2.2 Saudi Arabia: Middle East and Africa Pharmacogenomics Market Breakdown, by Application
    • 10.2.1.2.3 Saudi Arabia: Middle East and Africa Pharmacogenomics Market Breakdown, by End User
  • 10.2.1.3 UAE: Middle East and Africa Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.3.1 UAE: Middle East and Africa Pharmacogenomics Market Breakdown, by Technology
    • 10.2.1.3.2 UAE: Middle East and Africa Pharmacogenomics Market Breakdown, by Application
    • 10.2.1.3.3 UAE: Middle East and Africa Pharmacogenomics Market Breakdown, by End User
  • 10.2.1.4 Rest of Middle East and Africa: Middle East and Africa Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.4.1 Rest of Middle East and Africa: Middle East and Africa Pharmacogenomics Market Breakdown, by Technology
    • 10.2.1.4.2 Rest of Middle East and Africa: Middle East and Africa Pharmacogenomics Market Breakdown, by Application
    • 10.2.1.4.3 Rest of Middle East and Africa: Middle East and Africa Pharmacogenomics Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments

13. Company Profiles

13.1 Abbott
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 F. HOFFMANN-LA ROCHE LTD.
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Oxford Nanopore Technologies
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 THERMO FISHER SCIENTIFIC INC.
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Illumina, Inc.
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 QIAGEN
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Agilent Technologies, Inc.
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments

14. Appendix

14.1 About Business Market Insights
14.2 List of Abbreviations

The List of Companies - Middle East and Africa Pharmacogenomics Market

  • Abbott
  • F. HOFFMANN-LA ROCHE LTD.
  • Oxford Nanopore Technologies
  • THERMO FISHER SCIENTIFIC INC.
  • Illumina, Inc.
  • QIAGEN
  • Agilent Technologies, Inc.

    • Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now
    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)